Macquarie Group Ltd

SEC CIK: 0001418333
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overview All 13F holders of APLS Full Q2 2026 holdings

Shares (Q4 2025): 0; Sold out in Q4 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 18; Since Q1 2021

Holdings of APLS by Macquarie Group Ltd, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2025	0	$0	0.0%	−65,156−100.0%	Sold out	Holders
Q3 2025	65,156	$1.47M	<0.1%	+65,156	New	Holders
Q2 2025	0	$0	0.0%	−204,803−100.0%	Sold out	Holders
Q1 2025	204,803	$4.48M	<0.1%	+3,736+1.9%	Added	Holders
Q4 2024	201,067	$6.42M	<0.1%	+17,778+9.7%	Added	Holders
Q3 2024	183,289	$5.29M	<0.1%	−1,642−0.9%	Reduced	Holders
Q2 2024	184,931	$7.09M	<0.1%	−36,723−16.6%	Reduced	Holders
Q1 2024	221,654	$13.0M	<0.1%	−361,775−62.0%	Reduced	Holders
Q4 2023	583,429	$34.9M	<0.1%	−493,119−45.8%	Reduced	Holders
Q3 2023	1,076,548	$41.0M	0.1%	+301,068+38.8%	Added	Holders
Q2 2023	775,480	$70.6M	0.1%	−635,999−45.1%	Reduced	Holders
Q1 2023	1,411,479	$93.1M	0.1%	−50,163−3.4%	Reduced	Holders
Q4 2022	1,461,642	$75.6M	0.1%	+40,107+2.8%	Added	Holders
Q3 2022	1,421,535	$97.2M	0.1%	+38,028+2.7%	Added	Holders
Q2 2022	1,383,507	$62.6M	0.1%	+61,949+4.7%	Added	Holders
Q1 2022	1,321,558	$67.1M	0.1%	+29,775+2.3%	Added	Holders
Q4 2021	1,291,783	$61.1M	0.1%	+171,693+15.3%	Added	Holders
Q3 2021	1,120,090	$36.9M	<0.1%	+574,416+105.3%	Added	Holders
Q2 2021	545,674	$34.5M	<0.1%	+543,529+25,339.3%	Added	Holders
Q1 2021	2,145	$92.0K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.